HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: ps.035188.108v1 17/7/1241    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lee, C.-D. Articles by Wang, T.-F. Search for Related Content PubMed PubMed Citation Articles by Lee, C.-D. Articles by Wang, T.-F. Social Bookmarking                   What's this?

An improved SUMO fusion protein system for effective production of native proteins

¹ Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan
² Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan
³ Institute of Physics, Academia Sinica, Taipei 115, Taiwan
⁴ Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan
⁵ Vaccine Research and Development Center, National Health Research Center, Miaoli 350, Taiwan

(RECEIVED March 10, 2008; FINAL REVISION April 2, 2008; ACCEPTED April 3, 2008)

Expression of recombinant proteins as fusions with (small ubiquitin-related modifier) protein has significantly increased the yield of difficult-to-express proteins in Escherichia coli. The benefit of this technique is further enhanced by the availability of naturally occurring SUMO proteases, which remove SUMO from the fusion protein. Here we have improved the exiting SUMO fusion protein approach for effective production of native proteins. First, a sticky-end PCR strategy was applied to design a new SUMO fusion protein vector that allows directional cloning of any target gene using two universal cloning sites (Sfo1 at the 5'-end and XhoI at the 3'-end). No restriction digestion is required for the target gene PCR product, even the insert target gene contains a SfoI or XhoI restriction site. This vector produces a fusion protein (denoted as His₆-Smt3-X) in which the protein of interest (X) is fused to a hexahistidine (His₆)-tagged Smt3. Smt3 is the yeast SUMO protein. His₆-Smt3-X was purified by Ni²⁺ resin. Removal of His₆-Smt3 was performed on the Ni²⁺ resin by an engineered SUMO protease, His₆-Ulp1_403–621-His₆. Because of its dual His₆ tags, His₆-Ulp1_403–621-His₆ exhibits a high affinity for Ni² resin and associates with Ni²⁺ resin after cleavage reaction. One can carry out both fusion protein purification and SUMO protease cleavage using one Ni²⁺-resin column. The eluant contains only the native target protein. Such a one-column protocol is useful in developing a better high-throughput platform. Finally, this new system was shown to be effective for cloning, expression, and rapid purification of several difficult-to-produce authentic proteins.

Keywords: fusion protein; SUMO; Rad51; RecA; enterovirus; foot-and-mouth disease virus

Reprint requests to: Ting-Fang Wang, Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan; e-mail: tfwang{at}gate.sinica.edu.tw; fax: 886-2-27889759; or Chih-Hsiang Leng, Vaccine Research and Development Center, National Health Research Center, Miaoli 350, Taiwan; e-mail: leoleng{at}nhri.org.tw; fax: 886-37-583009.

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.035188.108.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?